IP Library Granted Patent US 9,023,090
Granted Patent B2
US 9,023,090 · App. 13/788,154 · Granted May 5, 2015

Treating cancer using electromagnetic fields in combination with photodynamic therapy

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,023,090
App. No.
13/788,154
Granted
May 5, 2015
Kind
B2
Abstract

A light generating circuit is implanted in a subject's body and aimed at a target region such as a tumor. A photosensitizer is introduced into the target region, and an AC electric field is induced in the region. The field causes the light generating circuit to generate light, which activates the photosensitizer; and at certain field strengths and frequencies, the field itself has a beneficial effect. The beneficial effects of the field and the activated photosensitizer are thereby obtained simultaneously.

Claims (10)

1. A method of treating cancer in a target region within a subject's body, the method comprising the steps of:

introducing a photosensitizer into cancer tissue in the target region;

implanting, into the subject's body, a light source aimed at the target region, the light source having a first contact and a second contact, wherein the light source generates light that activates the photosensitizer, and wherein the light source is powered by the application of an AC electric field; and

capacitively coupling, into the target region, an AC electric field that has frequency and field strength characteristics such that (i) passage of the electric field through dividing cells in the target region damages a significant portion of the dividing cells and (ii) passage of the electric field through non-dividing cells leaves the non-dividing cells substantially unharmed,

wherein the same AC electric field that is capacitively coupled into the target region also powers the light source by inducing a potential difference between the first contact and the second contact.

2. The method of claim 1 , wherein the light source comprises a light-emitting diode.

3. The method of claim 1 , wherein the AC electric field has a frequency between 100 kHz and 300 kHz.

4. The method of claim 1 , wherein the photosensitizer damages cancer cells when it is activated by illumination.

5. The method of claim 1 , wherein the light source comprises a light-emitting diode, the AC electric field has a frequency between 100 kHz and 300 kHz, and the photosensitizer damages cancer cells when it is activated by illumination.

6. The method of claim 1 , wherein the target region comprises a tumor.

Assignments (16)
PATENT SECURITY AGREEMENT Recorded May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →
RELEASE OF SECURITY INTEREST Recorded Apr 24, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NOVOCURE GMBH
Reel/Frame 067211/0839 →
SECURITY INTEREST Recorded Nov 6, 2020
From: NOVOCURE GMBH
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 054344/0510 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 45278 0825 Recorded Aug 25, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 053597/0335 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 50395/0398 Recorded Aug 19, 2020
From: BPCR LIMITED PARTNERSHIP
To: NOVOCURE GMBH
Reel/Frame 053538/0623 →
OMNIBUS CONFIRMATION OF ASSIGNMENT AGREEMENT Recorded May 21, 2020
From: BIOPHARMA CREDIT PLC
To: BPCR LIMITED PARTNERSHIP
Reel/Frame 052741/0173 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 045278/0825 Recorded Apr 14, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052391/0549 →
RELEASE OF SECURITY INTEREST Recorded Apr 13, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052383/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2019
From: NOVOCURE LIMITED
To: NOVOCURE GMBH
Reel/Frame 050110/0098 →
SECURITY INTEREST Recorded May 6, 2019
From: NOVOCURE GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 050395/0398 →
SECURITY INTEREST Recorded Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045278/0825 →
RELEASE OF SECURITY INTEREST Recorded Feb 7, 2018
From: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
To: NOVOCURE LIMITED
Reel/Frame 044858/0416 →
SECURITY INTEREST Recorded Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045284/0851 →
SECURITY INTEREST Recorded Feb 2, 2015
From: NOVOCURE LIMITED
To: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
Reel/Frame 034866/0402 →
CHANGE OF NAME Recorded Dec 29, 2014
From: STANDEN LIMITED
To: NOVOCURE LIMITED
Reel/Frame 034594/0061 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2014
From: PALTI, YORAM
To: STANDEN LTD.
Reel/Frame 034531/0445 →